Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne W Bell

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancerLecia V Sequist, Daphne W Bell, Thomas J Lynch, et al.
Cancer Genetics|November 4, 2019
High-resolution copy number analysis of clear cell endometrial carcinomaAndrea J O'Hara, Matthieu Le Gallo, Meghan L Rudd, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2007
Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinibGermano Zampa, Michele Moscato, Brian W Brannigan, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2016
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic DevelopmentGennady Margolin, Hanna M Petrykowska, Nader Jameel, et al.
Cancer Research|April 12, 2011
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancerMary E Urick, Meghan L Rudd, Andrew K Godwin, et al.
Cancer Research|March 3, 2007
Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinibRoseann Mulloy, Audrey Ferrand, Youngjoo Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphismsDaphne W Bell, Brian W Brannigan, Keitaro Matsuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2011
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomasMeghan L Rudd, Jessica C Price, Sarah Fogoros, et al.
Epigenetics|October 24, 2013
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell linesFrancisco Sánchez-Vega, Valer Gotea, Hanna M Petrykowska, et al.
Cell|August 31, 2002
salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell linesNicolas Tapon, Kieran F Harvey, Daphne W Bell, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancerLecia V Sequist, Daphne W Bell, Thomas J Lynch, et al.
Cancer Genetics|November 4, 2019
High-resolution copy number analysis of clear cell endometrial carcinomaAndrea J O'Hara, Matthieu Le Gallo, Meghan L Rudd, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2007
Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinibGermano Zampa, Michele Moscato, Brian W Brannigan, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2016
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic DevelopmentGennady Margolin, Hanna M Petrykowska, Nader Jameel, et al.
Cancer Research|April 12, 2011
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancerMary E Urick, Meghan L Rudd, Andrew K Godwin, et al.
Cancer Research|March 3, 2007
Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinibRoseann Mulloy, Audrey Ferrand, Youngjoo Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphismsDaphne W Bell, Brian W Brannigan, Keitaro Matsuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2011
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomasMeghan L Rudd, Jessica C Price, Sarah Fogoros, et al.
Epigenetics|October 24, 2013
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell linesFrancisco Sánchez-Vega, Valer Gotea, Hanna M Petrykowska, et al.
Cell|August 31, 2002
salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell linesNicolas Tapon, Kieran F Harvey, Daphne W Bell, et al.
Pageof 7